Search details
1.
Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection.
Nat Immunol
; 22(11): 1428-1439, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34471264
2.
Human CD8+ T cell cross-reactivity across influenza A, B and C viruses.
Nat Immunol
; 20(5): 613-625, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30778243
3.
TMPRSS2 is a functional receptor for human coronavirus HKU1.
Nature
; 624(7990): 207-214, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37879362
4.
SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.
EMBO J
; 40(24): e108944, 2021 12 15.
Article
in English
| MEDLINE | ID: mdl-34601723
5.
Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation.
J Immunol
; 208(6): 1389-1395, 2022 03 15.
Article
in English
| MEDLINE | ID: mdl-35246495
6.
IRF8 regulates efficacy of therapeutic anti-CD20 monoclonal antibodies.
Eur J Immunol
; 52(10): 1648-1661, 2022 10.
Article
in English
| MEDLINE | ID: mdl-36030374
7.
Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.
EMBO Rep
; 21(2): e49351, 2020 02 05.
Article
in English
| MEDLINE | ID: mdl-31833228
8.
Human Mucosal-Associated Invariant T Cells in Older Individuals Display Expanded TCRαß Clonotypes with Potent Antimicrobial Responses.
J Immunol
; 204(5): 1119-1133, 2020 03 01.
Article
in English
| MEDLINE | ID: mdl-31988181
9.
Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2.
J Infect Dis
; 224(6): 983-988, 2021 09 17.
Article
in English
| MEDLINE | ID: mdl-33693749
10.
Characteristics Associated with Olfactory and Taste Disorders in COVID-19.
Neuroepidemiology
; 55(5): 381-386, 2021.
Article
in English
| MEDLINE | ID: mdl-34198303
11.
SARS-CoV-2 infection in schools in a northern French city: a retrospective serological cohort study in an area of high transmission, France, January to April 2020.
Euro Surveill
; 26(15)2021 04.
Article
in English
| MEDLINE | ID: mdl-33860747
12.
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies.
Nat Commun
; 14(1): 824, 2023 02 14.
Article
in English
| MEDLINE | ID: mdl-36788246
13.
Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies.
bioRxiv
; 2022 Nov 21.
Article
in English
| MEDLINE | ID: mdl-36415455
14.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
J Exp Med
; 219(7)2022 07 04.
Article
in English
| MEDLINE | ID: mdl-35704748
15.
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Cell Rep Med
; 2(5): 100275, 2021 05 18.
Article
in English
| MEDLINE | ID: mdl-33899033
16.
Release of infectious virus and cytokines in nasopharyngeal swabs from individuals infected with non-alpha or alpha SARS-CoV-2 variants: an observational retrospective study.
EBioMedicine
; 73: 103637, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34678613
17.
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection.
Sci Adv
; 7(34)2021 08.
Article
in English
| MEDLINE | ID: mdl-34407944
18.
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Nat Med
; 27(5): 917-924, 2021 05.
Article
in English
| MEDLINE | ID: mdl-33772244
19.
A monocyte/dendritic cell molecular signature of SARS-CoV-2-related multisystem inflammatory syndrome in children with severe myocarditis.
Med
; 2(9): 1072-1092.e7, 2021 09 10.
Article
in English
| MEDLINE | ID: mdl-34414385
20.
Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients.
Nat Commun
; 12(1): 2691, 2021 05 11.
Article
in English
| MEDLINE | ID: mdl-33976217